Prediction and assessment of COPD lung volume reduction outcomes with polarized MRI

使用偏振 MRI 预测和评估 COPD 肺减容结果

基本信息

  • 批准号:
    9051246
  • 负责人:
  • 金额:
    $ 75.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2020-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is an increasingly urgent public health concern on both the national and global levels. Not only is the disorder a major cause of mortality, but the dyspnea, reduced capacity for physical exertion, and periodic exacerbations that it causes result in tremendous disability and cost. Treatment options for established COPD remain limited in number, diversity, and effectiveness. However, in recent years, significant innovation has been accomplished in the field of lung volume reduction (LVR), which seeks to enhance global lung function through the removal, occlusion, or obliteration of hyperinflated, emphysematous regions. While LVR has traditionally been implemented through surgical resection, the development of less invasive bronchoscopic techniques (BLVR) is ongoing and represents an extremely promising arena of COPD therapy. This application proposes to develop a hyperpolarized 129Xe magnetic resonance imaging (HP 129Xe MRI) approach for planning BLVR intervention and assessing its pulmonary effects. The core problem faced by all LVR approaches is that they have demonstrated highly variable outcomes; it consequently remains unclear exactly what types of patient will benefit most from this therapy and why. Clinicians currently base their decisions of whether to carry out LVR and which regions to target using high-resolution computed tomography (HRCT) to measure the extent of emphysema and its distribution. While HRCT is highly capable of accurately assessing these features, it does not provide the functional information necessary to gain a comprehensive understanding of an individual patient's regional pulmonary status. We thus posit that the incorporation of functional parameters obtained with HP 129Xe MRI will allow for more informed decision-making in regards to which patients should undergo LVR and how the procedure should be tailored according to the lung health of the particular patient. In applying HP 129Xe MRI to this medical area of need, a corollary goal will be achieved: the refinement of this hyperpolarized technique such that it can extract pulmonary information with the sensitivity of the more well-established HP 3He MRI approach. 3He has become drastically more expensive in recent years due to its scarcity, and the hyperpolarized community recognizes that a shift to the much less expensive and more easily obtainable 129Xe is necessary to ensure the translational applicability of this important technology. We seek here to use Xe to derive three lung parameters-specific ventilation (SV), alveolar oxygen tension (pAO2), 129 and apparent diffusion coefficient (ADC)-with approximately the same sensitivity and efficiency that we have previously attained using 3He. This development will enhance the clinical future of hyperpolarized MRI not only in the area of LVR, but also in the non-invasive assessment of COPD and lung diseases more broadly.
 描述(申请人提供):慢性阻塞性肺疾病(COPD)在国家和全球层面上都是一个日益紧迫的公共卫生问题。这种疾病不仅是死亡的主要原因,而且呼吸困难、体力活动能力下降以及由此导致的周期性恶化都会导致巨大的残疾和成本。已确诊的COPD的治疗选择在数量、多样性和有效性方面仍然有限。然而,近年来,肺减容术(LVR)领域取得了重大创新,它寻求通过移除、闭塞或闭塞过度膨胀的肺气肿区域来增强全球肺功能。虽然传统上肺减容术是通过手术切除实施的,但侵入性较小的支气管镜技术(BLVR)的发展正在进行中,代表着COPD治疗的一个非常有前途的领域。本申请建议开发一种超极化129Xe磁共振成像(HP 129Xe MRI)方法,用于计划BLVR干预和评估其对肺的影响。所有LVR方法面临的核心问题是,它们显示了高度不同的结果;因此,目前尚不清楚哪种类型的患者将从这种治疗中受益最多,以及为什么。目前,临床医生使用高分辨率计算机断层扫描(HRCT)来测量肺气肿的程度及其分布,以决定是否进行LVR以及针对哪些区域。虽然HRCT能够高度准确地评估这些特征,但它不能提供全面了解单个患者的区域肺状况所需的功能信息。因此,我们认为,结合HP 129Xe MRI获得的功能参数将允许就哪些患者应该接受LVR以及如何根据特定患者的肺部健康情况做出更明智的决策。在将HP 129Xe MRI应用于这一医疗需求领域时,将实现一个必然的目标:改进这种超极化技术,使其能够以更成熟的HP 3He MRI方法的灵敏度提取肺部信息。3近年来,由于129Xe的稀缺性,它的价格急剧上升,而两极分化的社区认识到,为了确保这项重要技术的翻译适用性,有必要转向成本低得多、更容易获得的129Xe。在这里,我们寻求使用Xe来推导三个肺参数--比通气量(SV)、肺泡氧分压(PAO2)、129和表观弥散系数(ADC)--其灵敏度和效率与我们以前使用3He获得的大致相同。这一进展将增强超极化MRI的临床前景,不仅在LVR领域,而且在更广泛的COPD和肺部疾病的无创性评估中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAHIM R RIZI其他文献

RAHIM R RIZI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAHIM R RIZI', 18)}}的其他基金

Imaging the functional response of the lung to bronchoscopic lung volume reduction
成像肺对支气管镜肺减容的功能反应
  • 批准号:
    10528137
  • 财政年份:
    2022
  • 资助金额:
    $ 75.7万
  • 项目类别:
Imaging the functional response of the lung to bronchoscopic lung volume reduction
成像肺对支气管镜肺减容的功能反应
  • 批准号:
    10680458
  • 财政年份:
    2022
  • 资助金额:
    $ 75.7万
  • 项目类别:
Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging
使用超极化 129Xe 成像预测肺移植受者慢性排斥反应的发生
  • 批准号:
    10192820
  • 财政年份:
    2020
  • 资助金额:
    $ 75.7万
  • 项目类别:
The sixth international workshop on metabolic imaging
第六届代谢影像国际研讨会
  • 批准号:
    10063645
  • 财政年份:
    2020
  • 资助金额:
    $ 75.7万
  • 项目类别:
Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging
使用超极化 129Xe 成像预测肺移植受者慢性排斥反应的发生
  • 批准号:
    10407561
  • 财政年份:
    2020
  • 资助金额:
    $ 75.7万
  • 项目类别:
Improving lung transplant outcomes through the use of imaging in a DBD rat model
通过在 DBD 大鼠模型中使用成像来改善肺移植结果
  • 批准号:
    9764471
  • 财政年份:
    2018
  • 资助金额:
    $ 75.7万
  • 项目类别:
Improving lung transplant outcomes through the use of imaging in a DBD rat model
通过在 DBD 大鼠模型中使用成像来改善肺移植结果
  • 批准号:
    10198021
  • 财政年份:
    2018
  • 资助金额:
    $ 75.7万
  • 项目类别:
Prediction and assessment of COPD lung volume reduction outcomes with polarized MRI
使用偏振 MRI 预测和评估 COPD 肺减容结果
  • 批准号:
    9228404
  • 财政年份:
    2016
  • 资助金额:
    $ 75.7万
  • 项目类别:
Imaging-based characterization of the COPDGene cohort
COPDGene 队列的基于成像的表征
  • 批准号:
    9127347
  • 财政年份:
    2015
  • 资助金额:
    $ 75.7万
  • 项目类别:
A New Approach for the Assessment of Pulmonary Inflammation
评估肺部炎症的新方法
  • 批准号:
    9010971
  • 财政年份:
    2015
  • 资助金额:
    $ 75.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 75.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了